tickdelta
Sign in
Screener / SEC EDGAR /CIK 0000927653 /10-K filed May 8, 2026, compared with May 9, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
CICAHCORCVSMCKUNH
NYSE Health care · Drug Wholesale

McKesson MCK

MCK quote by TradingView
Employees
43,000
Headquarters
Irving, TX
CEO
Brian S. Tyler
Next results
around Feb 3, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2026

Revenue of $403.4B through the costs to a net profit of $4.8B · income statement of the 10-K

2% operating margin
Revenue to Gross profit: $14.6BRevenue to Cost of revenue: $388.9BGross profit to Operating profit: $6.2BGross profit to Operating expenses: $8.3BOperating profit to Net profit: $4.8BOperating profit to Tax & other: $1.4B Revenue: $403.4B REVENUE $403.4B +12% Y/Y Gross profit: $14.6B · 4% margin GROSS PROFIT $14.6B 4% margin · +9% Y/Y Cost of revenue: $388.9B · 96% of revenue COST OF REVENUE $388.9B 96% of revenue Operating profit: $6.2B · 2% margin OPERATING PROFIT $6.2B 2% margin · +40% Y/Y Operating expenses: $8.3B · 2% of revenue OPERATING EXPENSES $8.3B 2% of revenue Net profit: $4.8B · 1% margin NET PROFIT $4.8B 1% margin · +45% Y/Y Tax & other: $1.4B · 0% of revenue TAX & OTHER $1.4B 0% of revenue
Gross profit $14.6B 4% margin · +9% Y/Y
Operating profit $6.2B 2% margin · +40% Y/Y
Net profit $4.8B 1% margin · +45% Y/Y
The full income statement, year by year

MCK among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 59 peers the company is above, not a score.

Compare
Revenue growth: 12.4%, above 83% of 59 peers (their median 7.1%) REVENUE GROWTH 12.4% · above 83% Gross margin: 3.7%, above 0% of 50 peers (their median 65.2%) GROSS MARGIN 3.7% · above 0% Operating margin: 1.6%, above 16% of 50 peers (their median 13.7%) OPERATING MARGIN 1.6% · above 16% Net margin: 1.1%, above 15% of 59 peers (their median 9.7%) NET MARGIN 1.1% · above 15% FCF margin: 1.7%, above 5% of 55 peers (their median 15.8%) FCF MARGIN 1.7% · above 5%
MCK Peer median Below the median

What changed

6 new risk paragraphs. 10-K filed May 8, 2026 against May 9, 2025.

Risk factors
6 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Accounting checks
11 other checks clear
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
6 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 11 checks found nothing to note

  • Receivables +9.1% vs revenue +12.4% (-3.2 pts)
  • Cash from operations $6.2B vs net income $4.8B (FY ending Mar 31, 2026)
  • Inventory +5.2% vs revenue +12.4% (-7.1 pts)
8 more checks with nothing to note
  • Same auditor in both 10-Ks: Deloitte & Touche LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Uncertain Tax Position, Opioid-Related Claims; Table of Contents Item 8 Index; McKESSON CORPORATION
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

6 paragraphs in Risk Factors that were not in the 10-K filed May 9, 2025. Quoted as filed.

All 6 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed May 9, 2025 10-K, ITEM 1A
    Anti-bribery and anti-corruption laws increase our compliance burden and expose us to risks.
  2. Item 1A · new paragraph · not in the 10-K filed May 9, 2025 10-K, ITEM 1A
    The adoption and use of AI in our business operations exposes us to risks and uncertainties. We increasingly rely on technologies powered by or incorporating AI in our internal operations and business processes. The use of AI technologies introduces risks and uncertainties. AI can generate outputs that are false, misleading, incomplete,…
  3. Item 1A · new paragraph · not in the 10-K filed May 9, 2025 10-K, ITEM 1A
    Our planned separation of Medical-Surgical Solutions is contingent upon the satisfaction of certain conditions, may not be completed on the currently contemplated terms or timeline, or at all, and, if completed, may not achieve the intended financial and strategic benefits. The Company intends to separate the Medical-Surgical Solutions…
  4. Item 1A · new paragraph · not in the 10-K filed May 9, 2025 10-K, ITEM 1A
    As described under “Healthcare Program Regulation” in Item 1 of Part I above, our business is subject to a broad range of recent and ongoing reform efforts, and challenges to those efforts, that could affect healthcare program access and spending, pharmaceutical pricing and reimbursement, and distribution economics. These include: the…

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2023FY2024FY2025FY2026
Revenue$276.7B$309.0B$359.1B$403.4B
Net income$3.6B$3.0B$3.3B$4.8B
Operating cash flow$5.2B$4.3B$6.1B$6.2B
Free cash flow$4.8B$3.9B$5.5B$5.7B

Revenue, FY2017 to FY2026

Ten fiscal years, each from its own 10-K · XBRL · USD

$403.4B ▲ 12.4% in FY2026

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Every number, year by year

Recent filings

6 filings in the last 30 days · SEC EDGAR

All filings
1 more

About the company

McKesson, Irving, TX · from the 10-K filed May 8, 2026

Section Page General 3 Business Segments 4 North American Pharmaceutical 4 Oncology & Multispecialty 7 Prescription Technology Solutions 8 Medical-Surgical Solutions 8 Investments, Restructuring, Business Combinations, and Divestitures 8 Competition 8 Patents, Trademarks, Copyrights, and Licenses 9 Human Capital 9 Government Regulation 10 Other Information about the Business 13 Forward-Looking Statements 14 McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhe…

Headquarters
Irving, TX
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
March 31
Last results
Nov 4, 2026
Incorporated in
DE

Employees, at the top of the page: "As of March 31, 2026, we had more than 43,000 employees worldwide, which includes 1,400 part-time employees" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed May 8, 2026 (open at SEC), compared with the 10-K filed May 9, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MCK/export.csv") into a cell.